Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections.

Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E, Köves B, Naber K, Perepanova T, Tenke P, Wullt B, Bogenhard F, Johansen TE.

Pathogens. 2016 Jan 19;5(1). pii: E10. doi: 10.3390/pathogens5010010.

2.

Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013.

Tandoğdu Z, Bartoletti R, Cai T, Çek M, Grabe M, Kulchavenya E, Köves B, Menon V, Naber K, Perepanova T, Tenke P, Wullt B, Johansen TE, Wagenlehner F.

World J Urol. 2016 Aug;34(8):1193-200. doi: 10.1007/s00345-015-1722-1.

3.

Health-Related Quality Of Life And Subjective Happiness Of Patients With Benign Prostatic Hyperplasia: First Results Of A Cross-Sectional Survey From Hungary.

Rencz F, Kovács Á, Gulacsi L, Majoros A, Nyirády P, Tenke P, Németh Z, Nagy GJ, Nagy J, Buzogány I, Böszörményi-Nagy G, Brodszky V.

Value Health. 2014 Nov;17(7):A471-2. doi: 10.1016/j.jval.2014.08.1339. No abstract available.

4.

[Our experience with totally extraperitoneal technique of laparoscopic inguinal hernia repairs modified by Stolzenburg].

Kesserű B, Kecskédi B, Polányi C, Réti A, Saftics G, Völgyi R, Kovács B, Tenke P, Ender F, Vörös A.

Magy Seb. 2014 Jun;67(3):129-34. doi: 10.1556/MaSeb.67.2014.3.8. Hungarian.

PMID:
24873769
5.

Healthcare-associated urinary tract infections in hospitalized urological patients--a global perspective: results from the GPIU studies 2003-2010.

Cek M, Tandoğdu Z, Wagenlehner F, Tenke P, Naber K, Bjerklund-Johansen TE.

World J Urol. 2014 Dec;32(6):1587-94. doi: 10.1007/s00345-013-1218-9.

PMID:
24452449
6.

An update on prevention and treatment of catheter-associated urinary tract infections.

Tenke P, Köves B, Johansen TE.

Curr Opin Infect Dis. 2014 Feb;27(1):102-7. doi: 10.1097/QCO.0000000000000031. Review.

PMID:
24345923
7.

Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study.

Tandogdu Z, Cek M, Wagenlehner F, Naber K, Tenke P, van Ostrum E, Johansen TB.

World J Urol. 2014 Jun;32(3):791-801. doi: 10.1007/s00345-013-1154-8.

PMID:
23979151
8.

Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial.

van Kerrebroeck P, Chapple C, Drogendijk T, Klaver M, Sokol R, Speakman M, Traudtner K, Drake MJ; NEPTUNE Study Group..

Eur Urol. 2013 Dec;64(6):1003-12. doi: 10.1016/j.eururo.2013.07.034.

9.

Antibiotic prophylaxis in urology departments, 2005-2010.

Çek M, Tandoğdu Z, Naber K, Tenke P, Wagenlehner F, van Oostrum E, Kristensen B, Bjerklund Johansen TE; Global Prevalence Study of Infections in Urology Investigators..

Eur Urol. 2013 Feb;63(2):386-94. doi: 10.1016/j.eururo.2012.09.038.

PMID:
23031676
10.

Reply from Authors re: Riccardo Bartoletti, Tommaso Cai. Prostate Biopsies Should Be Performed According to a Standard of Care. Eur Urol 2013;63:528-9.

Wagenlehner F, van Oostrum E, Tenke P, Tandogdu Z, Cek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE.

Eur Urol. 2013 Mar;63(3):529-30. doi: 10.1016/j.eururo.2012.07.037. No abstract available.

PMID:
22868669
11.

Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.

Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, Çek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE; GPIU investigators..

Eur Urol. 2013 Mar;63(3):521-7. doi: 10.1016/j.eururo.2012.06.003.

PMID:
22704727
12.

Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system.

Johansen TE, Botto H, Cek M, Grabe M, Tenke P, Wagenlehner FM, Naber KG.

Int J Antimicrob Agents. 2011 Dec;38 Suppl:64-70. doi: 10.1016/j.ijantimicag.2011.09.009. Review.

PMID:
22018988
13.

Preoperative assessment of the patient and risk factors for infectious complications and tentative classification of surgical field contamination of urological procedures.

Grabe M, Botto H, Cek M, Tenke P, Wagenlehner FM, Naber KG, Bjerklund Johansen TE.

World J Urol. 2012 Feb;30(1):39-50. doi: 10.1007/s00345-011-0722-z. Review.

PMID:
21779836
14.

Update on biofilm infections in the urinary tract.

Tenke P, Köves B, Nagy K, Hultgren SJ, Mendling W, Wullt B, Grabe M, Wagenlehner FM, Cek M, Pickard R, Botto H, Naber KG, Bjerklund Johansen TE.

World J Urol. 2012 Feb;30(1):51-7. doi: 10.1007/s00345-011-0689-9. Review.

15.

Bacterial hypermutation: clinical implications.

Jolivet-Gougeon A, Kovacs B, Le Gall-David S, Le Bars H, Bousarghin L, Bonnaure-Mallet M, Lobel B, Guillé F, Soussy CJ, Tenke P.

J Med Microbiol. 2011 May;60(Pt 5):563-73. doi: 10.1099/jmm.0.024083-0. Review.

PMID:
21349992
16.

Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study.

Howell AB, Botto H, Combescure C, Blanc-Potard AB, Gausa L, Matsumoto T, Tenke P, Sotto A, Lavigne JP.

BMC Infect Dis. 2010 Apr 14;10:94. doi: 10.1186/1471-2334-10-94.

17.

Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.

Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, Nicolle LE; Infectious Diseases Society of America..

Clin Infect Dis. 2010 Mar 1;50(5):625-63.

18.

[Thromboembolism--risk, prevention and therapy. Practice Guideline].

Magyar Thrombosis és Haemostasis Társaság.; Transzfuziológiai és Haematológiai Szakmai Kollégium..

Orv Hetil. 2009 Dec 27;150(52):2335-404. doi: 10.1556/OH.2009.28789. Hungarian. No abstract available.

PMID:
20031519
19.

Denosumab in men receiving androgen-deprivation therapy for prostate cancer.

Smith MR, Egerdie B, Hernández Toriz N, Feldman R, Tammela TL, Saad F, Heracek J, Szwedowski M, Ke C, Kupic A, Leder BZ, Goessl C; Denosumab HALT Prostate Cancer Study Group..

N Engl J Med. 2009 Aug 20;361(8):745-55. doi: 10.1056/NEJMoa0809003.

20.

[European and Asian guidelines on management and prevention of catheter-associated urinary tract infections].

Tenke P, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG; European Urologist Association, Urologist Association of Asia..

Urologiia. 2008 Nov-Dec;(6):84-91. Russian. No abstract available.

PMID:
19248605
Items per page

Supplemental Content

Loading ...
Support Center